Probi develops, produces, markets and sells probiotics globally to food, health and pharmaceutical companies. Probiotics are living microorganisms that have a beneficial effect on health when taken in a sufficient amount. The company's research focuses primarily on gastrointestinal health, immune systems, nutritional and iron intake and metabolic health. The Group is organized in two business areas - Consumer HealthCare and Functional Food.
We believe that Probi will benefit from the solid underlying market growth (c. 4% market growth) on the probiotics market and develop products in several different indications. We see opportunity for Probi to continue to deliver high sales growth in the Consumer HealthCare segment and in addition we see good opportunities in the Functional Food segment.
We note a number of risks factors for Probi, including market risk, partnership risk, competition, legal and regulatory risk, product development risk and currency and macroeconomic risk. In addition, Probi is dependent on a customer that constitutes a large part of the Group's total sales.